1.
Laganà A, Assanto GM, Masucci C, Passucci M, Donzelli L, Serrao A, et al. SECONDARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM (VTE) WITH LOW DOSE APIXABAN OR RIVAROXABAN: RESULTS FROM A PATIENT POPULATION WITH MORE THAN 2 YEARS OF MEDIAN FOLLOW-UP. Mediterr J Hematol Infect Dis [Internet]. 2024 Feb. 29 [cited 2024 May 11];16(1):e2024020. Available from: https://www.mjhid.org/mjhid/article/view/5567